GM-CSF inhibits glial scar formation and shows long-term protective effect after spinal cord injury

Journal of the Neurological Sciences

Volumn 277, Issue 1-2, 2009, Pages 87-97

  Huang, Xian ^a,b   Kim, Jin Mo ^a   Kong, Tae Ho ^a   Park, So Ra ^a   Ha, Yoon ^a   Kim, Moon Hang ^a   Park, Hyeonseon ^a   Yoon, Seung Hwan ^a   Park, Hyung Chun ^a   Park, Jong Oon ^a   Min, Byoung Hyun ^c   Choi, Byung Hyune ^a  

^a Inha University School of Medicine   (South Korea)

^b YANBIAN UNIVERSITY   (China)

^c Ajou University School of Medicine   (South Korea)

Author keywords

Cavitation; Chondroitin sulfate proteoglycans (CSPGs); Glial scars; GM CSF; Neuroprotection; Spinal cord injury

Indexed keywords

CORE PROTEIN; FAST BLUE; GELFOAM; GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN; NEUROCAN; NEUROMODULIN; PROTEOCHONDROITIN SULFATE; RECOMBINANT COLONY STIMULATING FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLIP; CONTROLLED STUDY; GLIA; GRAY MATTER; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NERVE FIBER REGENERATION; NEUROFILAMENT; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RANDOMIZATION; RAT; SCAR FORMATION; SPINAL CORD INJURY; TISSUE REPAIR;

ANIMALS; AXONS; CICATRIX; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MALE; MICROGLIA; PROTEOCHONDROITIN SULFATES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES;

EID: 58149302834     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.10.022     Document Type: Article

References (48)

1. Sandvig A., Berry M., Barrett L.B., Butt A., and Logan A. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 46 (2004) 225-251
2. Fitch M.T., Doller C., Combs C.K., Landreth G.E., and Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci 19 (1999) 8182-8198
3. Jones L.L., Margolis R.U., and Tuszynski M.H. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 182 (2003) 399-411
4. Matthews R.T., Kelly G.M., Zerillo C.A., Gray G., Tiemeyer M., and Hockfield S.J. Aggrecan glycoforms contribute to the molecular heterogeneity of perineuronal nets. J Neurosci 22 (2002) 7536-7547
5. Silver J., and Miller J.H. Regeneration beyond the glial scar. Nat Rev Neurosci 5 (2004) 146-156
6. Raisman G. Myelin inhibitors: does NO mean GO?. Nat Rev Neurosci 5 (2004) 157-161
7. Armitage J.O. Emerging applications of recombinant human granulocyte-macrophage colony stimulating factor. Blood 92 (1998) 4491-4508
8. Franzen R., Bouhy D., and Schoenen J. Nervous system injury: focus on the inflammatory cytokine 'granulocyte-macrophage colony stimulating factor'. Neurosci Lett 361 (2004) 76-78
9. Kannan Y., Moriyama M., Sugano T., Yamate J., Kuwamura M., Kagaya A., et al. Neurotrophic action of interleukin 3 and granulocyte-macrophage colony stimulating factor on murine sympathetic neurons. Neuroimmunomodulation 8 (2000) 132-141
10. Kim J.K., Choi B.H., Park H.C., Park S.R., Kim Y.S., Yoon S.H., et al. Effects of GM-CSF on the neural progenitor cells. NeuroReport 15 (2004) 2161-2165
11. Saada A., Reichert F., and Rotshenker S. Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells. J Cell Biol 133 (1996) 159-167
12. Ousman S.S., and David S. MIP-1a, MCP-1, GM-CSF, and TNF-a control the immune cell response that mediate rapid phagocytosis of myelin from the adult mouse spinal cord. J Neurosci 21 (2001) 4649-4656
13. Hughes P.M., and Perry V.H. The role of macrophages in degeneration and regeneration in the peripheral nervous system. In: Saunders N.R., and Dziegielewska K.M. (Eds). Degeneration and Regeneration in the Nervous System (2000), Harwood Academic, Chichester, UK 263-283
14. David S., and Ousman S.S. Recruiting the immune response to promote axon regeneration in the injured spinal cord. Neuroscientist 8 (2002) 33-41
15. Schermer C., and Humpel C. Granulocyte-macrophage colony-stimulating factor activates microglia in rat cortex organotypic brain slices. Neurosci Lett 328 (2002) 180-184
16. Bouhy D., Malgrange B., Multon S., Poirrier A.L., Scholtes F., Schoenen J., et al. Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages. FASEB J 20 (2006) 493-502
17. Ha Y., Kim Y.S., Cho J.M., Yoon S.H., Park S.R., Yoon D.H., et al. Role of granulocyte macrophage colony stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury. J Neurosurg Spine 2 (2004) 55-61
18. Park H.C., Shim Y.S., Ha Y., Yoon S.H., Park S.R., Choi B.H., et al. Treatment of spinal cord injury patients with bone marrow cell transplantation and GM-CSF treatment. Tissue Eng 11 (2005) 913-922
19. Yoon S.H., Shim Y.S., Park Y.H., Chung J.K., Nam J.H., Kim M.O., et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells 25 (2007) 2066-2073
20. Huang X., Choi J.K., Park S.R., Ha Y., Park H., Yoon S.H., et al. GM-CSF inhibits apoptosis of neural cells via regulating the expression of apoptosis-related proteins. Neurosci Res 58 (2007) 50-57
21. Ooka K., Shibuya M., and Suzuki Y. A comparative study of intracranial aneurysm clips: closing and opening forces and physical endurance. Neurosurgery 40 (1997) 318-323
22. Poon P.C., Gupta D., Shoichet M.S., and Tator C.H. Clip compression model is useful for thoracic spinal cord injuries: histologic and functional correlates. Spine 32 (2007) 2853-2859
23. Choi J.K., Choi B.H., Ha Y., Park H., Yoon S.H., Park H.C., et al. Signal transduction pathways of GM-CSF in neural cell lines. Neurosci Lett 15 (2007) 217-222
24. McKerracher L., David S., Jackson D.L., Kottis V., Dunn R.J., and Braun P.E. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite outgrowth. Neuron 13 (1994) 805-811
25. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., et al. Nogo-A is a myelin associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403 (2000) 434-438
26. Wang K.C., Koprivica V., Kim J.A., Sivasankaran R., Guo Y., Neve R., et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417 (2002) 941-944
27. Iannotti C., Zhang Y.P., Shields L.B., Han Y., Burke D.A., Xu X.M., et al. Dural repair reduces connective tissue scar invasion and cystic cavity formation after acute spinal cord laceration injury in adult rats. J Neurotrauma 23 (2006) 853-865
28. Biernaskie J., Sparling J.S., Liu J., Shannon C.P., Plemel J.R., Xie Y., et al. Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. J Neurosci 27 (2007) 9545-9559
29. Curtis R., Green D., Lindsay R.M., and Wilkin G.P. Upregulation of GAP-43 and growth of axons in rat spinal cord after compression injury. J Neurocytol 22 (1993) 51-64
30. Li G.L., Farooque M., Holtz A., and Olsson Y. Increased expression of growth-associated protein 43 immunoreactivity in axons following compression trauma to rat spinal cord. Acta Neuropathol 92 (1996) 19-26
31. Schmitt A.B., Breuer S., Voell M., Schwaiger F.-W., Spitzer Ch., Pech K., et al. GAP-43 (B-50) and C-Jun are up-regulated in axotomized neurons of Clarke's nucleus after spinal cord injury in the adult rat. Neurobiol Dis 6 (1999) 122-130
32. Strata P., Buffo A., and Rossi F. Mechanisms of axonal plasticity. Arch Ital Biol 137 (1999) 181-192
33. Roitbak T., and Sykova E. Diffusion barriers evoked in the rat cortex by reactive astrogliosis. Glia 28 (1999) 40-48
34. Okada S., Nakamura M., Katoh H., Miyao T., Shimazaki T., Ishii K., et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 12 (2006) 829-834
35. Hynds D.L., and Snow D.M. Neurite outgrowth inhibition by chondroitin sulfate proteoglycan: stalling/stopping exceeds turning in human neuroblastoma growth cones. Exp Neurol 160 (1999) 244-255
36. Johnson W.E., Caterson B., Eisenstein S.M., Hynds D.L., Snow D.M., and Roberts S. Human intervertebral disc aggrecan inhibits nerve growth in vitro. Arthritis Rheum 46 (2002) 2658-2664
37. Snow D.M., Mullins N., and Hynds D.L. Nervous system-derived chondroitin sulfate proteoglycans regulate growth cone morphology and inhibit neurite outgrowth: a light, epifluorescence, and electron microscopy study. Microsc Res Tech 54 (2001) 273-286
38. Selles-Navarro I., Ellezam B., Fajardo R., Latour M., and McKerracher L. Retinal ganglion cell and nonneuronal cell responses to a microcrush lesion of adult rat optic nerve. Exp Neurol 167 (2001) 282-289
39. Zhang Y., Tohyama K., Winterbottom J.K., Haque N.S., Schachner M., Lieberman A.R., et al. Correlation between putative inhibitory molecules at the dorsal root entry zone and failure of dorsal root axonal regeneration. Mol Cell Neurosci 17 (2001) 444-459
40. Tang X., Davies J.E., and Davies S.J. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res 71 (2003) 427-444
41. Asher R.A., Morgenstern D.A., Shearer M.C., Adcock K.H., Pesheva P., and Fawcett J.W. Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J Neurosci 22 (2002) 2225-2236
42. Imai Y., and Kohsaka S. Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia 40 (2002) 164-174
43. McGeer P.L., Itagaki S., Boyes B.E., and McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38 (1988) 1285-1291
44. McDonald D.R., Brunden K.R., and Landreth G.E. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J Neurosci 17 (1997) 2284-2294
45. Nakajima K., and Kohsaka S. Microglia: neuroprotective and neurotrophic cells in the central nervous system. Curr Drug Targets Cardiovasc Haematol Disord 4 (2004) 65-84
46. Batchelor P.E., Liberatore G.T., Wong J.Y., Porritt M.J., Frerichs F., Donnan G.A., et al. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 19 (1999) 1708-1716
47. Schwartz M., and Yoles E. Macrophages and dendritic cells treatment of spinal cord injury: from the bench to the clinic. Acta Neurochir Suppl 93 (2005) 147-150
48. Trigg M.E., Peters C., and Zimmerman M.B. Administration of recombinant human granulocyte-macrophage colony stimulating factor to children undergoing allogeneic marrow transplantation: a prospective, randomized, double-masked, placebo-controlled trial. Pediatr Transplant 4 (2000) 123-131